Results 161 to 168 of about 1,341 (168)

Frequency and Patterns of Hearing Dysfunction in Patients Treated with Teprotumumab

Ophthalmology
Tatiana Correa, Marlan Hansen, Chau Pham   +2 more
exaly  

The Rate of Re-treatment in Patients Treated with Teprotumumab

Ophthalmology
Raymond S Douglas, Sara Wester, Suzanne Freitag   +2 more
exaly  

Impact of Teprotumumab on Clinical Practice in Thyroid Eye Disease

Endocrine Practice
Andrea Tooley, Marius Stan, David Toro-Tobón   +2 more
exaly  

A comparison of proptosis reduction with teprotumumab versus surgical decompression based on fat-to-muscle ratio in thyroid eye disease

Orbit
Jin Sook Yoon, Bobby S Korn, Don O Kikkawa   +2 more
exaly  

Orbital decompression surgery among Medicare beneficiaries in the post‐teprotumumab era

International Forum of Allergy and Rhinology
Vinay Rathi, Akash M Bhat
exaly  

Teprotumumab-Related Adverse Events in Thyroid Eye Disease

Ophthalmology
Shreya Shāh, Andrea Kössler, Madhura A Tamhankar   +2 more
exaly  

A randomised, double-masked, placebo-controlled trial evaluating the efficacy and safety of teprotumumab for active thyroid eye disease in Japanese patients

The Lancet Regional Health - Western Pacific
Tomoko Hayashida, Takashi Akamizu, Mika Tanabe   +2 more
exaly  

Carbimazole/Teprotumumab

Reactions Weekly
openaire   +1 more source